Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer
- PMID: 30741325
- PMCID: PMC11028144
- DOI: 10.1007/s00262-019-02312-0
Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer
Abstract
The development of new approaches to breast cancer (BC) early diagnosis is an important objective of modern oncology. Although the role of the immune system in cancer initiation process was experimentally well established, the prognostic value of cellular blood immunological parameters (CBIPs) for BC onset prediction was not demonstrated either in clinics or in mouse models. In this study, we focused on revealing informative CBIPs for mammary cancer (MC) onset prediction in the BLRB/BYRB mouse model with a high incidence of natural MC development. Blood samples were collected from 80 aging females of these original mouse strains, 12 basic CBIPs were estimated by flow cytometry. Then mice were followed up for 28 weeks, and the outcome of females (MC diagnosis, death without MC or MC-free survival) was registered. We estimated the patterns of changes in CBIPs with age and in accordance with the outcome. An increasing imbalance in 11 CBIPs during natural aging of females clearly resembled human immunosenescence phenomenon and several patterns corresponded to the results obtained on cancer-free members of BC-affected families. We stratified heterogeneous female population into middle-aged and old subgroups. Low NK-cell levels in middle-aged mice and low B-cell along with high T-helper levels in old mice distinguished females with developed MC from the other groups. We found a reliable correlation of several CBIPs with age at MC diagnosis and survival of cancer-bearing females. Thus, we demonstrated the predictive potential of CBIPs as a basis for the development of prognostic models for BC onset in clinics.
Keywords: Breast cancer; Cellular blood immunological parameters; Immune system; Mouse model.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures





Similar articles
-
Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.Front Immunol. 2018 Aug 15;9:1894. doi: 10.3389/fimmu.2018.01894. eCollection 2018. Front Immunol. 2018. PMID: 30158936 Free PMC article.
-
Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.Breast Cancer Res Treat. 2012 Feb;131(3):751-63. doi: 10.1007/s10549-011-1452-z. Epub 2011 Mar 30. Breast Cancer Res Treat. 2012. PMID: 21448671
-
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.J Transl Med. 2015 Jun 27;13:204. doi: 10.1186/s12967-015-0567-0. J Transl Med. 2015. PMID: 26116238 Free PMC article. Clinical Trial.
-
Tumor infiltrating lymphocytes in early breast cancer.Breast. 2018 Feb;37:207-214. doi: 10.1016/j.breast.2017.03.010. Epub 2017 Mar 28. Breast. 2018. PMID: 28363679 Review.
-
[Lymphocytes of the blood, regional lymph nodes and tumor tissue in breast cancer].Vopr Onkol. 1988;34(9):1040-8. Vopr Onkol. 1988. PMID: 3055674 Review. Russian. No abstract available.
Cited by
-
Impact of Breast Tumor Onset on Blood Count, Carcinoembryonic Antigen, Cancer Antigen 15-3 and Lymphoid Subpopulations Supported by Automatic Classification Approach: A Pilot Study.Cancer Control. 2021 Jan-Dec;28:10732748211048612. doi: 10.1177/10732748211048612. Cancer Control. 2021. PMID: 34620015 Free PMC article.
References
-
- Den Otter W, Merchant TE, Beijerinck D, Koten JW. Breast cancer induction due to mammographic screening in hereditarily affected women. Anticancer Res. 1996;16:3173–3175. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical